Joyo Pharma's JYP0035 Receives Clinical Trial Approval for Breast Cancer Treatment
CompanyDrug

Joyo Pharma’s JYP0035 Receives Clinical Trial Approval for Breast Cancer Treatment

CDE Announces 92nd Batch of Reference Preparations for Generic Drug Evaluation
Policy / Regulatory

CDE Announces 92nd Batch of Reference Preparations for Generic Drug Evaluation

HutchMed's 2024 Financial Report Shows Dip in Revenue Amid Oncology Product Growth
Company

HutchMed’s 2024 Financial Report Shows Dip in Revenue Amid Oncology Product Growth

Servier and Black Diamond Therapeutics Ink Global Deal for BDTX-4933
CompanyDeals

Servier and Black Diamond Therapeutics Ink Global Deal for BDTX-4933

NMPA Seeks Public Input on Drug Trial Data Protection Measures
Policy / Regulatory

NMPA Seeks Public Input on Drug Trial Data Protection Measures

Telix Pharmaceuticals Gains Brazilian Approval for Prostate Cancer Diagnostic Agent TLX591-CDx
CompanyMedical Device

Telix Pharmaceuticals Gains Brazilian Approval for Prostate Cancer Diagnostic Agent TLX591-CDx

Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services
CompanyDeals

Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services

Pfizer Restructures China Operations to Boost Growth and Innovation
Company

Pfizer Restructures China Operations to Boost Growth and Innovation

CDE's 2024 Annual Drug Review Report Shows Continued Growth in Regulatory Filings
Policy / Regulatory

CDE’s 2024 Annual Drug Review Report Shows Continued Growth in Regulatory Filings

Everest Medicines Initiates Jiashan Plant for Etrasimod Tablet Production
Company

Everest Medicines Initiates Jiashan Plant for Etrasimod Tablet Production

GE Healthcare and NVIDIA Expand Partnership to Advance Autonomous X-ray and Ultrasound Technologies
CompanyDeals

GE Healthcare and NVIDIA Expand Partnership to Advance Autonomous X-ray and Ultrasound Technologies

Tonghua Dongbao Initiates Phase III Trial for Insulin Degludec, Liraglutide Combo in Type 2 Diabetes
CompanyDrug

Tonghua Dongbao Initiates Phase III Trial for Insulin Degludec, Liraglutide Combo in Type 2 Diabetes